ArticleNature medicine2019
Development of a CRISPR/Cas9-based therapy for Hutchinson-Gilford progeria syndrome.
Olaya Santiago-Fernández et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
105 papers cite itlatest 60 shown
this papertrialcites it